BACE1 and Alzheimer disease: Experimentally, the overexpression of MMP-13 also causes AD, and the administration of MMP-13 inhibitors attenuates the cognitive dysfunction in AD transgenic mice via the beta-site of amyloid precursor protein cleaving enzyme 1 (BACE1) regulation [28].